{"id":77126,"date":"2026-02-05T12:04:39","date_gmt":"2026-02-05T12:04:39","guid":{"rendered":"https:\/\/english.saigonbiz.com\/vn\/sagimet-biosciences-announces-participation-in-two-upcoming-investor-conferences\/"},"modified":"2026-02-05T12:04:39","modified_gmt":"2026-02-05T12:04:39","slug":"sagimet-biosciences-announces-participation-in-two-upcoming-investor-conferences","status":"publish","type":"post","link":"https:\/\/english.saigonbiz.com\/vn\/sagimet-biosciences-announces-participation-in-two-upcoming-investor-conferences\/","title":{"rendered":"Sagimet Biosciences Announces Participation in Two Upcoming Investor Conferences"},"content":{"rendered":"<div>\n<p>SAN MATEO, Calif., Feb.  05, 2026  (GLOBE NEWSWIRE) &#8212; Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic and fibrotic pathways, today announced that management will participate in two upcoming investor conferences.<\/p>\n<ul type=\"disc\">\n<li>Guggenheim Emerging Outlook: Biotech Summit 2026 in New York, NY, on February 11, 2026, with a fireside chat at 10am ET (link <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=coh3jnYWkhezz6_sd3pIrK_EOc5sNfB_sABFv9ah3ejxRhqvC3hmbMWwlGcLt9FK30LS93PB3eKeB-pHuYUjxVNtM9hK9p9M2iWgaDlf_P5VVstopHXWZ66B5i1yD19aICWae37cn0TZHvYkz7ORIHSN14GCfI-zZNYvbJaxmF3Oi-wUX1CDmPLY-nbNHc85Q5cEcjHUOml2pJYOLZR-wCzSRXLRIGMxD436801-cjci5F4IhiOS9iLfF6Nxy4wRzJ5bZ1sX_yafPldWbhRrJhfwEEAziGXzjblUvMSTKjVh4xPW0lfZWx7i3VuEFGlglDWJ4GGKSgbq16Jin9E91sLCTLqQuFcCxUlKalefAoA-UJ833h_vcH4njJ6C8KpRi-qRuCDIyukER9AGAhNi0RBMDx7koU1hUaPFE--cBipWOMt-CTRYEbyQscNyz-kd\" rel=\"nofollow\" target=\"_blank\" title=\"here\">here<\/a>).<\/li>\n<li>Oppenheimer 36<sup>th<\/sup> Annual Healthcare Life Sciences Conference on February 26, 2026, with a fireside chat at 9:20am ET (link <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=coh3jnYWkhezz6_sd3pIrDcUZIb-CW9xNb-lRsQk8osWCA4VyhHU-EsmG4B0bVmELamE2DCdUWlDyUI5w2WLLpCoL5hjhD3WZfKDmC52HfNdkYeUMvYIY7AYWnOyW-Xak63l_etZMFP1Z4_4d6qql1R3Tf7c3fotjIqgzO7VWGBeF6BeQi_LTRehQRHadaocnbbZ9p7OHXfBhz8DVHKThMwoSfq5drk1DIhTy7AqshdjvTJs2RrWzfgZDsd7mhkpSvivvw9spcU7EvWhnzOpevUk3efq3zqivK8_vu70Mf4cDwDQoz_w40VMakidgySCadyDb9BfOkiFmaSAlY5PqHLnJzlpLUpCbY4SlJ6KKdbshVVAxxC_FodUgIUbx6NiSdGanaIzbQ8YdCGJmYZlMzsv-eC8xCw8nOrh2WFGn_9A1Sl4TcPNOzAkbkklkHVp\" rel=\"nofollow\" target=\"_blank\" title=\"here\">here<\/a>).<\/li>\n<\/ul>\n<p>The Guggenheim and Oppenheimer fireside chats will be available in the Investors &amp; Media section of Sagimet\u2019s website at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=dKSj-pgNJZxZQ46RZjUAltnA1K0fM4YH80nlIkZiIU9ZksooA6DALTbGU2wVwaAdmlDE9Eyyo09zc2Z1VkdaWuCm71QxKZMkuqi2qhNbPeeJbL_IWASAJeRfrJJanALEzJ-nDyeg_rQuchcm_W6nfQLC9w7lIa7Vo8B-dMcB3yQbPXf6iMwpPO442cscqhTLO3Q_3biveUPZ9yAvaJJiXNSkirZ-_2CnC_cqr81TrjXIJ7rdNex9VIp4vlinWMuJ4o7EQuz028SGp46NQlwrThR1UAZQaTIJyOqZLqzQQiZG-EX4jlsDw7dBEKfZjodGyOXtwiTLjS77fP7NFGb6vHaxFkWteMYIKOma5BnbZUH_8T7-8XAt78A_NxyHKy6PweFkKCRj-ClCn4fcHDYZXPkupoMa1s114QOhFcKHFlwLKpI57fbB1Glf2_VqAURCkC6kO9uke2xnJ60MuvhBvAFm38L7JWiuYha7_4vvzBWG7a-ueHUBJBLDfzjQt4EADJFlSJDO_30cM-IH_tbbNmaWjlWunZQ-4e8Q4BhKOpCLKdVcAfuju-AfVinpzMSXWmEc7Y1nlS3qugcrMUnaCvtJ6ksAckNEbkEFJRLvjMf4079U74jqRSuWz45rcYXYIhJ9AOM6T0B51EAhVUoKWWHpYQVasXVLG6bkObtpWpsq2BZCmSwfLtkEz9PCvSgwrZ0H5XKTWloBUVuCgW5GENsZ79cZAwFaCl7JK6kfaibvsTMoFdOY1wglIcAV4GGpZbVxj8AjaqVTsbX1ccXIcbY9v4qn_ChLn9pKsH0OYSEMfQKS1OyVQk54VSfAoYsqP_5rzNIkVuktAtJpPTpNYsZqueU9SryHekqS3e6OBtq6kh1klkvwF5YK2S8NqAV6x04tfZLYun4NFYftOvYrr5mizrV2AjvJi9_dOgNJAHEjtNDGRviyjyb-LTTmSxIeAs_E7vHbWkdlLLcDDGdM37HH2aFGIPsyQtzd0M0lasAIvqq4B24OYdhgrBTKe1tlnPvKSgrbdv3VaweF3z9b6t-rfrgtHknoSq3TjU9zIb44FI_GQJCX0GjL9KszjsqEOwbApJ0HzTAfua1PNKwbQi2elolx5FXybRH2Qo68gU7zY0FwKXvitLoIt-yuLDApAld9C3hE59a6XexcNchsniPoUn0VpZnqvW3zyMRF4fgTutteAFgkoQytEx3fMu9AmCxxSH_YPgkEXVguAWv2o_el6Rx-inOmdz8R4bid-D0N5Ij7ZLgtHWKjdZBZTASzOJlX9t11CT88V7GXqx535x95kbiGmlBh568VUag3uWgdi9_78WDVrVEZmc1y0rsUp7lGb2Qd8wV1rB5KBzRPrVnzYTBGHFtPhfCgcGZ4K47QbQ6sY8GEfcVrzKkWp99tTxPCTyPq5XcRWJ2E6QQ77Fj3UiA-kWXXxNAq14GX0fSbz8VOUxUtuS9mj8BMnEJLuDCp6WZjFhVZWm5K0YMT-X2WmhviF7YPqga7iHF0bkWDR1-wasfJac5skIuvo0EboePgZ-vPp8wKFNSZtPkPgJQmpAE_rY6JJb_bbB6OQaY62MEx6UfU7st2zGUUd15KjmgpXmkxiG5XgaTRrt1Lj3iCKURFNkxkBNeVf2J2xG91ItKtXsaFzYdR90UZS3h47USQyaEPZyVBjL1hvrvD8ZlLlr5gD3me8btD8BZ9980Ls9hY88TI4NMccdUmtLbhcymZ2pAKWA4jMDK0LR04pXOZhIwT_BeCj_3Gby0oJ72FMmM-IGF7XvJ5jLD9FsGFFsQAi0QEuJhdbXQ5aTs_5D1_U5oe8DoAxT3NzpwFQOtpLPwVG05wTzR6_jmHOsiAd5iOcLKDgDjAwge2ZceDWVemBL9dgiIGeeHZ2kXnQvbxi4H41J5GG7ZQWI9bYjB8d4Yu0cEdq1yApOSrgjWMOHe9SgNMzr135XKpQd1dr-aLcvN25NLLcXkpCX5hK_1FpSLa3n1SNMh1I0zZA3MgYGB2UZXfdHzJFBJql2y78TTtrhYrtxytRdhAWpEbi8N6sGuiF6G_Ddsgpc5DwHJHSZn-YkcqgiP2-2otzajy3DOzwFQi3tqwlQXmR0vs1Eb-LqLSSMPIxlB38pgo-YINRKDmMijGecxeKY4OMjJbc9IdUExRbG_tmi6bjrmfiZ0uiNkCQqYm3tT3KSG-4TpvDw==\" rel=\"nofollow\" target=\"_blank\" title=\"www.sagimet.com\">www.sagimet.com<\/a>, with an archived replay available for 90 days following the live event.<\/p>\n<p align=\"justify\"><strong>About Sagimet Biosciences <\/strong><\/p>\n<p align=\"justify\">Sagimet is a clinical-stage biopharmaceutical company developing novel FASN inhibitors designed to target dysfunctional metabolic and fibrotic pathways in conditions resulting from the overproduction of the fatty acid, palmitate. Denifanstat, an oral, once-daily pill, met all primary endpoints in its Phase 2b FASCINATE-2 clinical trial in MASH as well as all primary and secondary endpoints in Sagimet\u2019s license partner for China\u2019s Phase 3 clinical trial in moderate-to-severe acne. A combination of denifanstat and resmetirom is currently being tested in a Phase 1 PK clinical trial and is planned to be developed for cirrhotic patients living with F4-stage MASH. TVB-3567, a second oral FASN inhibitor which is planned to be developed for acne, is currently being tested in a Phase 1 first-in-human clinical trial. For additional information about Sagimet, please visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=dKSj-pgNJZxZQ46RZjUAlq0-ADLhfgYi8toZf5rC6QK_B5hwViRO9MP4b3cZ4otI9W6aPY6AkDQEWiN5Hed_3Fc72rmUb8GdifWT0BbirzbIzd9WX9OpSD-6Jts-AxHjiwJr1oO7XrvLYYlNh0iq7nJ92vKiVH28NCWWS1DiD-cZiHlQcuG3-53isjChdzmn5ib7BYp0kenMY_4ZQIWS5MJ8c_usHRAPJrR4w93TkDfZ0wl5b0txfM73hsj-XuLeAioZDmIsxPxoPHcFatohjJ681QFh87Ej9H0pZueMN_gIP3t5ULRcFovezCItDgwKA8btVoW8hv3IZrFjYrS4FTDHvkMW3xr9nvIroloKtPD628rhqsarsfgnVZz41h03EjX0qnbAIlbtaqJfnOi_nTrx4577AjcvYQOKHZ0pjufAALSa2ZzULs_LmPYz3oX0LuXdhdbR3M2UsrBZ4dwzx9mbxhYqo19OqWerPIPMK58D84HU8VTwrhPMmQ6FuurqXt4JvSP9nrud_kNeeJm98UYONgJYXdwCahwdLbsmSDkuYIcz5_NDTe489OygiLBhyt2-iW-IXULwqNCQi6dR7zCYJErOnosneHSP8M53-rxfvP8mQ8HnqUz0Jr_RsvMUGi5gKS4_MMWQnmOaoxAy5TSwN1oEhUox9axzHuz4edxcTBDnkPhexNY1tkrNHNQ67W1lBnUIA76ek0OUvgA7wE0kNVktPRTLgis1uzqmL0c=\" rel=\"nofollow\" target=\"_blank\" title=\"www.sagimet.com\">www.sagimet.com<\/a>.<\/p>\n<p><strong>Investor Contact:<\/strong><br \/>Joyce Allaire\u00a0<br \/>LifeSci Advisors\u00a0<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=C_ws4iPOfyeb0eqi_WGaWGc1KNaZOYDrPKVS6eNDlhRNCgi_u3Z-dOTVQ_7GItxLF62JNeKNx6laYEPTpSd_2prQBdOBBFgQB6HsGBMKjHueCjKBdLGB8Eu4a8sng23CcVvJLlcoFV0Ftliq6OKhGBdnJUTbwKMb06JhgVHZ20fXqtZT1xE0K_7Ror43MC_24ZnezuwK5KQO-jKe0vRckPi_lanfhNnFfX8pgJUg0cYqO6EstOZ_hIqo2-7NARy50pfaJW5FnANngrX6YHi_FZ7Evcssxf66j4tPMSfpPW2fqvDI_NTm6qduO0wfYuZZF8vguN1cLxA5InwaUXJunMJGLolUvsXEJ1DNTTwQyXxcWWY-ddc-vrAISoiGqZNXOzrARqpgjrJWaxE1DLLbHONrdkU4WN9Pm3_qyBxzuihvTdSxMGgcHW6mZvNady-mgpz9mXR7K25mb3AoODgXJTGUwapm2vQVZ32V1pNwjOpN29Q3e9YN5GiqYcvD9Ew70DCZ43n3tcmdwnXw3jdwOqrltwJ_CTSbkW5fif638A6FEkxz84939jpPtgfmGBt0LWJu_RvmsCUE2sQnuH7TA2b4XyNd5PxHYmhxqcZjQc8=\" rel=\"nofollow\" target=\"_blank\" title=\"JAllaire@LifeSciAdvisors.com\">JAllaire@LifeSciAdvisors.com<\/a><\/p>\n<p><strong>Media Contact:<\/strong><br \/>Maggie Whitney<br \/>LifeSci Communications<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=FsxyAW003NLupatdwLZ7A0Yq_E_7zbKfZe1PCm86GV0B9QuZx7hlU_l7v3dr7900rzNWZY109-VC0ESjoA-E10HJwekd7qNXVIYdNzUFmxWdb-Nf1c5Y0FTdnEWvfoRt\" rel=\"nofollow\" target=\"_blank\" title=\"mwhitney@lifescicomms.com\">mwhitney@lifescicomms.com<\/a><\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/YmZhM2FmNWQtYjY3My00MDY1LWE1NzAtYjBkMGQ3N2ViMjY3LTEyMjAyMDEtMjAyNi0wMi0wNS1lbg==\/tiny\/Sagimet-Biosciences-Inc-.png\" referrerpolicy=\"no-referrer-when-downgrade\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SAN MATEO, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) &#8212; Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic and fibrotic pathways, today announced that management will participate in two upcoming investor conferences. Guggenheim Emerging Outlook: Biotech Summit 2026 in New York, NY, on February 11, 2026, with a fireside [&#8230;]\n","protected":false},"author":1,"featured_media":77127,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-77126","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pr-newswire"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v21.6 (Yoast SEO v21.6) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Sagimet Biosciences Announces Participation in Two Upcoming Investor Conferences - Biz and Live in Saigon<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/english.saigonbiz.com\/vn\/sagimet-biosciences-announces-participation-in-two-upcoming-investor-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Sagimet Biosciences Announces Participation in Two Upcoming Investor Conferences\" \/>\n<meta property=\"og:description\" content=\"SAN MATEO, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) &#8212; Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developi\" \/>\n<meta property=\"og:url\" content=\"https:\/\/english.saigonbiz.com\/vn\/sagimet-biosciences-announces-participation-in-two-upcoming-investor-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Biz and Live in Saigon\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/SaigonbizGroup\" \/>\n<meta property=\"article:published_time\" content=\"2026-02-05T12:04:39+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/02\/Sagimet-Biosciences-Inc-.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1\" \/>\n\t<meta property=\"og:image:height\" content=\"1\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/sagimet-biosciences-announces-participation-in-two-upcoming-investor-conferences\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/sagimet-biosciences-announces-participation-in-two-upcoming-investor-conferences\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6\"},\"headline\":\"Sagimet Biosciences Announces Participation in Two Upcoming Investor Conferences\",\"datePublished\":\"2026-02-05T12:04:39+00:00\",\"dateModified\":\"2026-02-05T12:04:39+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/sagimet-biosciences-announces-participation-in-two-upcoming-investor-conferences\/\"},\"wordCount\":270,\"publisher\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\"},\"articleSection\":[\"Pr Newswire\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/sagimet-biosciences-announces-participation-in-two-upcoming-investor-conferences\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/sagimet-biosciences-announces-participation-in-two-upcoming-investor-conferences\/\",\"name\":\"Sagimet Biosciences Announces Participation in Two Upcoming Investor Conferences - Biz and Live in Saigon\",\"isPartOf\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#website\"},\"datePublished\":\"2026-02-05T12:04:39+00:00\",\"dateModified\":\"2026-02-05T12:04:39+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/sagimet-biosciences-announces-participation-in-two-upcoming-investor-conferences\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/english.saigonbiz.com\/vn\/sagimet-biosciences-announces-participation-in-two-upcoming-investor-conferences\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/sagimet-biosciences-announces-participation-in-two-upcoming-investor-conferences\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/english.saigonbiz.com\/vn\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Sagimet Biosciences Announces Participation in Two Upcoming Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#website\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/\",\"name\":\"Biz and Live in Saigon\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/english.saigonbiz.com\/vn\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\",\"name\":\"SaigonBiz Media\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png\",\"contentUrl\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png\",\"width\":512,\"height\":512,\"caption\":\"SaigonBiz Media\"},\"image\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/SaigonbizGroup\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png\",\"contentUrl\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png\",\"caption\":\"admin\"},\"sameAs\":[\"https:\/\/english.saigonbiz.com\/vn\"],\"url\":\"https:\/\/english.saigonbiz.com\/vn\/profile\/admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Sagimet Biosciences Announces Participation in Two Upcoming Investor Conferences - Biz and Live in Saigon","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/english.saigonbiz.com\/vn\/sagimet-biosciences-announces-participation-in-two-upcoming-investor-conferences\/","og_locale":"en_US","og_type":"article","og_title":"Sagimet Biosciences Announces Participation in Two Upcoming Investor Conferences","og_description":"SAN MATEO, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) &#8212; Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developi","og_url":"https:\/\/english.saigonbiz.com\/vn\/sagimet-biosciences-announces-participation-in-two-upcoming-investor-conferences\/","og_site_name":"Biz and Live in Saigon","article_publisher":"https:\/\/www.facebook.com\/SaigonbizGroup","article_published_time":"2026-02-05T12:04:39+00:00","og_image":[{"width":1,"height":1,"url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/02\/Sagimet-Biosciences-Inc-.png","type":"image\/png"}],"author":"admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/english.saigonbiz.com\/vn\/sagimet-biosciences-announces-participation-in-two-upcoming-investor-conferences\/#article","isPartOf":{"@id":"https:\/\/english.saigonbiz.com\/vn\/sagimet-biosciences-announces-participation-in-two-upcoming-investor-conferences\/"},"author":{"name":"admin","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6"},"headline":"Sagimet Biosciences Announces Participation in Two Upcoming Investor Conferences","datePublished":"2026-02-05T12:04:39+00:00","dateModified":"2026-02-05T12:04:39+00:00","mainEntityOfPage":{"@id":"https:\/\/english.saigonbiz.com\/vn\/sagimet-biosciences-announces-participation-in-two-upcoming-investor-conferences\/"},"wordCount":270,"publisher":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#organization"},"articleSection":["Pr Newswire"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/english.saigonbiz.com\/vn\/sagimet-biosciences-announces-participation-in-two-upcoming-investor-conferences\/","url":"https:\/\/english.saigonbiz.com\/vn\/sagimet-biosciences-announces-participation-in-two-upcoming-investor-conferences\/","name":"Sagimet Biosciences Announces Participation in Two Upcoming Investor Conferences - Biz and Live in Saigon","isPartOf":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#website"},"datePublished":"2026-02-05T12:04:39+00:00","dateModified":"2026-02-05T12:04:39+00:00","breadcrumb":{"@id":"https:\/\/english.saigonbiz.com\/vn\/sagimet-biosciences-announces-participation-in-two-upcoming-investor-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/english.saigonbiz.com\/vn\/sagimet-biosciences-announces-participation-in-two-upcoming-investor-conferences\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/english.saigonbiz.com\/vn\/sagimet-biosciences-announces-participation-in-two-upcoming-investor-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/english.saigonbiz.com\/vn\/"},{"@type":"ListItem","position":2,"name":"Sagimet Biosciences Announces Participation in Two Upcoming Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/english.saigonbiz.com\/vn\/#website","url":"https:\/\/english.saigonbiz.com\/vn\/","name":"Biz and Live in Saigon","description":"","publisher":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/english.saigonbiz.com\/vn\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/english.saigonbiz.com\/vn\/#organization","name":"SaigonBiz Media","url":"https:\/\/english.saigonbiz.com\/vn\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/","url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png","contentUrl":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png","width":512,"height":512,"caption":"SaigonBiz Media"},"image":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/SaigonbizGroup"]},{"@type":"Person","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6","name":"admin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/image\/","url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png","contentUrl":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png","caption":"admin"},"sameAs":["https:\/\/english.saigonbiz.com\/vn"],"url":"https:\/\/english.saigonbiz.com\/vn\/profile\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts\/77126","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/comments?post=77126"}],"version-history":[{"count":0,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts\/77126\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/media\/77127"}],"wp:attachment":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/media?parent=77126"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/categories?post=77126"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/tags?post=77126"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}